Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 CNS demyelination during anti-tumor necrosis factor alpha therapy.

Literature DB >> 16311894

CNS demyelination during anti-tumor necrosis factor alpha therapy.

Michele Bellesi, Francesco Logullo, Paolo Di Bella, Leandro Provinciali.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2005 PMID： 16311894 DOI： 10.1007/s00415-005-0055-1

Source DB: PubMed Journal: J Neurol ISSN： 0340-5354 Impact factor: 4.849

× No keyword cloud information.

11 in total

Review 1. New drugs for rheumatoid arthritis.

Authors: Nancy J Olsen; C Michael Stein
Journal: N Engl J Med Date: 2004-05-20 Impact factor: 91.245

Review 2. The tumor necrosis factor ligand and receptor families.

Authors: F Bazzoni; B Beutler
Journal: N Engl J Med Date: 1996-06-27 Impact factor: 91.245

3. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein.

Authors: L W Moreland; S W Baumgartner; M H Schiff; E A Tindall; R M Fleischmann; A L Weaver; R E Ettlinger; S Cohen; W J Koopman; K Mohler; M B Widmer; C M Blosch
Journal: N Engl J Med Date: 1997-07-17 Impact factor: 91.245

4. Onset of multiple sclerosis associated with anti-TNF therapy.

Authors: N L Sicotte; R R Voskuhl
Journal: Neurology Date: 2001-11-27 Impact factor: 9.910

5. TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group.

Authors:
Journal: Neurology Date: 1999-08-11 Impact factor: 9.910

6. Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis.

Authors: D Maimone; S Gregory; B G Arnason; A T Reder
Journal: J Neuroimmunol Date: 1991-04 Impact factor: 3.478

7. Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides.

Authors: N Mohan; E T Edwards; T R Cupps; P J Oliverio; G Sandberg; H Crayton; J R Richert; J N Siegel
Journal: Arthritis Rheum Date: 2001-12

8. Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum.

Authors: T Saxne; M A Palladino; D Heinegård; N Talal; F A Wollheim
Journal: Arthritis Rheum Date: 1988-08

9. Experimental autoimmune encephalomyelitis: immunotherapy with anti-tumor necrosis factor antibodies and soluble tumor necrosis factor receptors.

Authors: K W Selmaj; C S Raine
Journal: Neurology Date: 1995-06 Impact factor: 9.910

10. Tumor necrosis factor identified in multiple sclerosis brain.

Authors: F M Hofman; D R Hinton; K Johnson; J E Merrill
Journal: J Exp Med Date: 1989-08-01 Impact factor: 14.307

11 in total

Review 1. Janus-like effects of type I interferon in autoimmune diseases.

Authors: Robert C Axtell; Chander Raman
Journal: Immunol Rev Date: 2012-07 Impact factor: 12.988

2. Optic Neuritis Associated or Not with TNF Antagonists in Patients with Inflammatory Bowel Disease.

Authors: Benjamin Alexandre; Yves Vandermeeren; Olivier Dewit; Tom Moreels; Nanne de Boer; Anjan Dhar; Chris Ziady; Ariella Bar-Gil Shitrit; Flavio Steinwurz; Njegica Jojic; Giuseppe Costantino; Benoit Bihin; Jean-François Rahier; Konstantinos H Katsanos
Journal: J Crohns Colitis Date: 2016-01-12 Impact factor: 9.071

Review 3. A case of leukoencephalopathy associated with adalimumab-treated rheumatoid arthritis and a review of literature.

Authors: Yang-Seon Ryu; Sung-Hwan Park; Ji-Min Kim; Eun-Ji Kim; Jennifer Lee; Seung-Ki Kwok; Ji-Hyeon Ju; Ho-Youn Kim
Journal: Rheumatol Int Date: 2011-11-08 Impact factor: 2.631

10. Peculiar Cytological Cerebrospinal Fluid Pattern in a Case of Encephalomyelitis During Anti-Tumor Necrosis Factor-α Therapy.

Authors: Yana Motuzova; Alessia Di Sapio; Marco Capobianco; Arianna Sala; Fabiana Marnetto; Simona Malucchi; Antonio Bertolotto
Journal: Neurol Ther Date: 2015-03-06